Catalysts for Fresenius Kabi USA LLC

IDACIO (ADALIMUMAB-AACF) — FDA approval

TYENNE (TOCILIZUMAB-AAZG) — FDA approval

TYENNE (TOCILIZUMAB-AAZG) — FDA approval

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

TYENNE (TOCILIZUMAB-AAZG) — FDA approval

IFOSFAMIDE — FDA approval

IFOSFAMIDE — FDA approval

IDACIO (ADALIMUMAB-AACF) — FDA approval

VALPROATE SODIUM — FDA approval

VALPROATE SODIUM — FDA approval

FLUOROURACIL — FDA approval

FLUOROURACIL — FDA approval

TYENNE (TOCILIZUMAB-AAZG) — FDA approval

IDACIO (ADALIMUMAB-AACF) — FDA approval

MORPHINE SULFATE — FDA approval

DILAUDID-HP (HYDROMORPHONE HYDROCHLORIDE) — FDA approval

IDACIO (ADALIMUMAB-AACF) — FDA approval

IDACIO (ADALIMUMAB-AACF) — FDA approval

IDACIO (ADALIMUMAB-AACF) — FDA approval

STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approval

IDACIO (ADALIMUMAB-AACF) — FDA approval

STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approval

DIPRIVAN (PROPOFOL) — FDA approval

DIPRIVAN (PROPOFOL) — FDA approval

DILAUDID-HP (HYDROMORPHONE HYDROCHLORIDE) — FDA approval

MORPHINE SULFATE — FDA approval

DILAUDID-HP (HYDROMORPHONE HYDROCHLORIDE) — FDA approval

DILAUDID-HP (HYDROMORPHONE HYDROCHLORIDE) — FDA approval

DIPRIVAN (PROPOFOL) — FDA approval

DILAUDID-HP (HYDROMORPHONE HYDROCHLORIDE) — FDA approval